Impact of Intraoperative Molecular Imaging after Fluorescent-Guided Pulmonary Metastasectomy for Sarcoma.
Journal
Journal of the American College of Surgeons
ISSN: 1879-1190
Titre abrégé: J Am Coll Surg
Pays: United States
ID NLM: 9431305
Informations de publication
Date de publication:
01 05 2022
01 05 2022
Historique:
entrez:
15
4
2022
pubmed:
16
4
2022
medline:
19
4
2022
Statut:
ppublish
Résumé
Intraoperative molecular imaging (IMI) has been shown to improve lesion detection during pulmonary sarcomatous metastasectomy. Our goal in this study was to evaluate whether data garnered from IMI-guided resection of pulmonary sarcoma metastasis translate to improved patient outcomes. Fifty-two of 65 consecutive patients with a previous history of sarcomas found to have pulmonary nodules during screening were enrolled in a nonrandomized clinical trial. Patients underwent TumorGlow the day before surgery. Data on patient demographics, tumor biologic characteristics, preoperative assessment, and survival were included in the study analysis and compared with institutional historical data of patients who underwent metastasectomy without IMI. p values < 0.05 were considered significant. IMI detected 42 additional lesions in 31 patients (59%) compared with the non-IMI cohort where 25% percent of patients had additional lesions detected using tactile and visual feedback only (p < 0.05). Median progression-free survival (PFS) for patients with IMI-guided pulmonary sarcoma metastasectomy was 36 months vs 28.6 months in the historical cohort (p < 0.05). IMI-guided pulmonary sarcoma metastasectomy had recurrence in the lung with a median time of 18 months compared with non-IMI group at 13 months (p < 0.05). Patients with synchronous lesions in the IMI group underwent systemic therapy at a statistically higher rate and tended to undergo routine screening at shorter interval. IMI identifies a subset of sarcoma patients during pulmonary metastasectomy who have aggressive disease and informs the medical oncologist to pursue more aggressive systemic therapy. In this setting, IMI can serve both as a diagnostic and prognostic tool without conferring additional risk to the patient.
Sections du résumé
BACKGROUND
Intraoperative molecular imaging (IMI) has been shown to improve lesion detection during pulmonary sarcomatous metastasectomy. Our goal in this study was to evaluate whether data garnered from IMI-guided resection of pulmonary sarcoma metastasis translate to improved patient outcomes.
STUDY DESIGN
Fifty-two of 65 consecutive patients with a previous history of sarcomas found to have pulmonary nodules during screening were enrolled in a nonrandomized clinical trial. Patients underwent TumorGlow the day before surgery. Data on patient demographics, tumor biologic characteristics, preoperative assessment, and survival were included in the study analysis and compared with institutional historical data of patients who underwent metastasectomy without IMI. p values < 0.05 were considered significant.
RESULTS
IMI detected 42 additional lesions in 31 patients (59%) compared with the non-IMI cohort where 25% percent of patients had additional lesions detected using tactile and visual feedback only (p < 0.05). Median progression-free survival (PFS) for patients with IMI-guided pulmonary sarcoma metastasectomy was 36 months vs 28.6 months in the historical cohort (p < 0.05). IMI-guided pulmonary sarcoma metastasectomy had recurrence in the lung with a median time of 18 months compared with non-IMI group at 13 months (p < 0.05). Patients with synchronous lesions in the IMI group underwent systemic therapy at a statistically higher rate and tended to undergo routine screening at shorter interval.
CONCLUSIONS
IMI identifies a subset of sarcoma patients during pulmonary metastasectomy who have aggressive disease and informs the medical oncologist to pursue more aggressive systemic therapy. In this setting, IMI can serve both as a diagnostic and prognostic tool without conferring additional risk to the patient.
Identifiants
pubmed: 35426386
doi: 10.1097/XCS.0000000000000132
pii: 00019464-202205000-00006
pmc: PMC9460458
mid: NIHMS1815100
doi:
Types de publication
Clinical Trial
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
748-758Subventions
Organisme : NCI NIH HHS
ID : F32 CA254210
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA193556
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA251063
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2022 by the American College of Surgeons. Published by Wolters Kluwer Health, Inc. All rights reserved.
Références
Digesu CS, Wiesel O, Vaporciyan AA, et al. Management of sarcoma metastases to the lung. Surg Oncol Clin N Am 2016;25:721–733.
Marcove RC, Miké V, Hajek JV, et al. Osteogenic sarcoma under the age of twenty-one. A review of one hundred and forty-five operative cases. J Bone Joint Surg Am 1970;52:411–423.
Saltzman DA, Snyder CL, Ferrell KL, et al. Aggressive metastasectomy for pulmonic sarcomatous metastases: A follow-up study. Am J Surg 1993;166:543–547.
Predina JD, Puc MM, Bergey MR, et al. Improved survival after pulmonary metastasectomy for soft tissue sarcoma. J Thorac Oncol 2011;6:913–919.
Cerfolio RJ, Bryant AS, McCarty TP, et al. A prospective study to determine the incidence of non-imaged malignant pulmonary nodules in patients who undergo metastasectomy by thoracotomy with lung palpation. Ann Thorac Surg 2011;91:1696–700; discussion 1700.
Cerfolio RJ, McCarty T, Bryant AS. Non-imaged pulmonary nodules discovered during thoracotomy for metastasectomy by lung palpation. Eur J Cardiothorac Surg 2009;35:786–91; discussion 791.
Pastorino U, Buyse M, Friedel G, et alInternational Registry of Lung Metastases. Long-term results of lung metastasectomy: Prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg 1997;113:37–49.
Marulli G, Mammana M, Comacchio G, et al. Survival and prognostic factors following pulmonary metastasectomy for sarcoma. J Thorac Dis 2017;9(Suppl 12):S1305–S1315.
Martini N, Huvos AG, Miké V, et al. Multiple pulmonary resections in the treatment of osteogenic sarcoma. Ann Thorac Surg 1971;12:271–280.
Okiror L, Peleki A, Moffat D, et al. Survival following pulmonary metastasectomy for sarcoma. Thorac Cardiovasc Surg 2016;64:146–149.
Anon. Key Statistics for Soft Tissue Sarcomas. Available at: https://www.cancer.org/cancer/soft-tissue-sarcoma/about/key-statistics.html . Accessed March 27, 2021.
Treasure T, Fiorentino F, Scarci M, et al. Pulmonary metastasectomy for sarcoma: A systematic review of reported outcomes in the context of Thames Cancer Registry data. BMJ Open 2012;2:e001736.
Treasure T, Milošević M, Fiorentino F, et al. Pulmonary metastasectomy: What is the practice and where is the evidence for effectiveness? Thorax 2014;69:946–949.
Azari F, Kennedy G, Singhal S. Intraoperative detection and assessment of lung nodules. Surg Oncol Clin N Am 2020;29:525–541.
Reza J, Sammann A, Jin C, et al. Aggressive and minimally invasive surgery for pulmonary metastasis of sarcoma. J Thorac Cardiovasc Surg 2014;147:1193–200; discussion 1200.
Stahl M, Ranft A, Paulussen M, et al. Risk of recurrence and survival after relapse in patients with Ewing sarcoma. Pediatr Blood Cancer 2011;57:549–553.
Azari F, Kennedy G, Bernstein E, et al. Intraoperative molecular imaging clinical trials: A review of 2020 conference proceedings. JBO International Society for Optics and Photonics 2021;26:050901.
Newton AD, Predina JD, Corbett CJ, et al. Optimization of second window indocyanine green for intraoperative near-infrared imaging of thoracic malignancy. J Am Coll Surg 2019;228:188–197.
Predina JD, Newton AD, Keating J, et al. Intraoperative molecular imaging combined with positron emission tomography improves surgical management of peripheral malignant pulmonary nodules. Ann Surg 2017;266:479–488.
Newton AD, Predina JD, Nie S, et al. Intraoperative fluorescence imaging in thoracic surgery. J Surg Oncol 2018;118:344–355.
Singhall S. A pilot and feasibility study of intraoperative imagery of solid tumors with indocyanine green. 2018. Available at: https://clinicaltrials.gov/ct2/show/NCT02280954 .
Zeh R, Sheikh S, Xia L, et al. The second window ICG technique demonstrates a broad plateau period for near infrared fluorescence tumor contrast in glioblastoma. PLoS One 2017;12:e0182034.
Nagaya T, Nakamura YA, Choyke PL, et al. Fluorescence-guided surgery. Front Oncol 2017;7:314.
Newton AD, Predina JD, Shin MH, et al. Intraoperative near-infrared imaging can identify neoplasms and aid in real-time margin assessment during pancreatic resection. Ann Surg 2019;270:12–20.
Predina JD, Newton AD, Corbett C, et al. Near-infrared intraoperative imaging for minimally invasive pulmonary metastasectomy for sarcomas. J Thorac Cardiovasc Surg 2019;157:2061–2069.
Porter GA, Cantor SB, Walsh GL, et al. Cost-effectiveness of pulmonary resection and systemic chemotherapy in the management of metastatic soft tissue sarcoma: a combined analysis from the University of Texas M. D. Anderson and Memorial Sloan-Kettering Cancer Centers. J Thorac Cardiovasc Surg 2004;127:1366–1372.
Jeong do S, Park DH, Kim CY. Cutaneous metastatic undifferentiated pleomorphic sarcoma from a mediastinal sarcoma. Ann Dermatol 2015;27:310–314.
Nakamura T, Matsumine A, Yamada S, et al. Oncological outcome after lung metastasis in patients presenting with localized chondrosarcoma at extremities: Tokai Musculoskeletal Oncology Consortium study. Onco Targets Ther 2016;9:4747–4751.
Bindiganavile S, Han I, Yun JY, et al. Long-term outcome of chondrosarcoma: A single institutional experience. Cancer Res Treat 2015;47:897–903.
Boehme KA, Schleicher SB, Traub F, Rolauffs B. Chondrosarcoma: A rare misfortune in aging human cartilage? The role of stem and progenitor cells in proliferation, malignant degeneration and therapeutic resistance. Int J Mol Sci 2018;19.
Stephens EH, Blackmon SH, Correa AM, et al. Progression after chemotherapy is a novel predictor of poor outcomes after pulmonary metastasectomy in sarcoma patients. J Am Coll Surg 2011;212:821–826.